Attached files
| file | filename |
|---|---|
| 8-K - AEOLUS PHARMACEUTICALS, INC. 8-K - AEOLUS PHARMACEUTICALS, INC. | aeoluspharmaceuticalsinc8k.htm |
September 13, 2016
U.S. Securities and Exchange Commission
Office of the Chief Accountant
100 F Street, NE
Washington, DC 20549
Re: Aeolus Pharmaceuticals, Inc.
File No. 0-50481
Dear Sir or Madam:
We have read Item 4.01 of Form 8-K of Aeolus Pharmaceuticals, Inc. dated September 8, 2016, and agree with the statements concerning our Firm contained therein.
Very truly yours,
/s/ GRANT THORNTON LLP